Australian Adult Cancer Pain Management Guideline Working Party 2019, Australian adult cancer pain management guideline: ‘Cancer pain management in adults’, Cancer Council Australia, Sydney, viewed 6 June 2019, <https://wiki.cancer.org.au/australiawiki/index.php?oldid=191646>.

Australian Cancer Survivorship Centre 2016, ‘Survivorship care planning’, viewed 2 October 2020, <https://www.petermac.org/sites/default/files/page/downloads/Survivorship_Care_Planning.pdf>.

Australian Cancer Survivorship Centre 2019, Community support organisations’ cancer survivorship care consensus statement, viewed 10 February 2020, <https://www.petermac.org/sites/default/files/media-uploads/NGO_ConsensusStatement.pdf>.

Australian Clinical Trials 2015, ‘Potential benefits and risks’, National Health and Medical Research Council, Department of Industry, Innovation and Science, Australian Government, Canberra, viewed 24 July 2019, <https://www.australianclinicaltrials.gov.au/why-be-part-clinical-trial/potential-benefits-and-potential-risks>.

Australian Commission for Safety and Quality in Health Care (ACSQHC) 2015, Credentialing health practitioners and defining their scope of clinical practice: a guide for managers and practitioners, ACSQHC, Sydney, viewed 18 February 2020, <https://www.safetyandquality.gov.au/publications-and-resources/resource-library/credentialing-health-practitioners-and-defining-their-scope-clinical-practice-guide-managers-and-practitioners>.

Australian Commission for Safety and Quality in Health Care (ACSQHC) 2020, ‘NSQHS Standards user guide for medication management in cancer care’, ACSQHC, Sydney, viewed 16 April 2020, <https://www.safetyandquality.gov.au/publications-and-resources/resource-library/nsqhs-standards-user-guide-medication-management-cancer-care>.

Australian Commission on Safety and Quality in Health Care (ACSQHC) 2011, Patient-centred care: Improving quality and safety through partnerships with patients and consumers, ACSQHC, Sydney, viewed 17 March 2022.

Australian Commission on Safety and Quality in Health Care (ACSQHC) 2014, Health literacy: taking action to improve safety and quality, ACSQHC, Sydney, viewed 18 February 2020, <https://www.safetyandquality.gov.au/sites/default/files/migrated/Health-Literacy-Taking-action-to-improve-safety-and-quality.pdf>.

Australian Commission on Safety and Quality in Health Care (ACSQHC) 2017, National Safety and Quality Health Service Standards guide for hospitals, ACSQHC, Sydney, viewed 18 February 2020, <https://www.safetyandquality.gov.au/wp-content/uploads/2017/12/National-Safety-and-Quality-Health-Service-Standards-Guide-for-Hospitals.pdf>.

Australian Commission on Safety and Quality in Health Care (ACSQHC) 2019a, Person-centred care, ACSQHC, Sydney, viewed 15 May 2020, <https://www.safetyandquality.gov.au/our-work/partnering-consumers/person-centred-care>.

Australian Commission on Safety and Quality in Health Care (ACSQHC) 2019b, Australian Hospital Patient Experience Question Set, ACSQHC, Sydney, viewed 25 March 2020, <https://www.safetyandquality.gov.au/our-work/indicators-measurement-and-reporting/australian-hospital-patient-experience-question-set>.

Australian Government Department of Health (AGDH) 2021, National framework for advance care planning documents, AGDH, viewed 24 March 2022, <https://www.health.gov.au/resources/publications/national-framework-for-advance-care-planning-documents>.

Australian Institute of Health and Welfare (AIHW) 2016, Australia’s health 2016, Australia’s health series no. 15. Cat. no. AUS 199, AIHW, Canberra.
Australian Institute of Health and Welfare (AIHW) 2017, Access to health services by Australians with disability, viewed 20 February 2020, <https://www.aihw.gov.au/reports/disability/access-health-services-disability/contents/content>.

Australian Institute of Health and Welfare (AIHW) 2018, Australia’s health 2018, Australia’s health series no. 16. Cat. no. AUS 221, AIHW, Canberra.
Australian Institute of Health and Welfare (AIHW) 2021, Cancer data in Australia, Cancer summary data visualization: neuroendocrine tumours, viewed 9 December 2021, <https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/cancer-summary-data-visualisation>.

AYA Cancer Fertility Preservation Guidance Working Group 2014, Fertility preservation for AYAs diagnosed with cancer: guidance for health professionals, Cancer Council Australia, Sydney, viewed 20 July 2020, <https://wiki.cancer.org.au/australia/COSA:AYA_cancer_fertility_preservation/Introduction>.

Cancer Australia 2015, National Aboriginal and Torres Strait Islander cancer framework, Cancer Australia, Surry Hills, viewed 24 August 2017, <https://www.canceraustralia.gov.au/publications-and-resources/cancer-australia-publications/national-aboriginal-and-torres-strait-islander-cancer-framework>.

Cancer Australia 2017, Principles of cancer survivorship, Australian Government, Sydney, viewed 18 February 2020, <https://canceraustralia.gov.au/sites/default/files/publications/principles-cancer-survivorship/pdf/pocs_-_principles_of_cancer_survivorship.pdf>.

Cancer Australia 2019a, Principles of multidisciplinary care, Australian Government, Sydney, viewed 18 July 2019, <https://canceraustralia.gov.au/system/tdf/guidelines/all_about_multidisciplinary_care.pdf?file=1&type=node&id=3551>.

Cancer Australia 2019b, ‘Cancer incidence’, viewed 18 February 2020, <https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence>.

Cancer Australia 2020, Cancer care in the time of COVID-19: a conceptual framework for the management of cancer during a pandemic, Australian Government, Sydney, viewed 3 September 2020, <https://www.canceraustralia.gov.au/publications-and-resources/cancer-australia-publications/cancer-care-time-covid-19-conceptual-framework-management-cancer-during-pandemic>.

Cancer Australia 2021, Neuroendocrine tumours, viewed 9 December 2021 <https://www.canceraustralia.gov.au/cancer-types/neuroendocrine-tumours/statistics>.

Cancer Centre 2021, About Neuroendocrine tumors 2021, viewed 27 September 2021, <https://www.cancercenter.com/cancer-types/neuroendocrine-tumors/about>.

Cancer Council Australia 2018, ‘Prevention’, Cancer Council Australia, Sydney, viewed 18 July 2019, <https://www.cancer.org.au/preventing-cancer/>.

Cancer Council Australia 2019, ‘Complementary and alternative therapies’, Cancer Council Australia, Sydney, viewed 22 July 2019, <https://www.cancer.org.au/about-cancer/treatment/complementary-therapies-and-cancer.html>.

Cancer Council Victoria 2019, ‘Palliative care’, Cancer Council Victoria, viewed 7 October 2019, <https://www.cancervic.org.au/cancer-information/treatments/treatments-types/palliative_care/palliative-care-treatment.html>.

Cancer Research in Primary Care 2016, Principles statement: Shared care, PC4 Shared Care Working Group, Melbourne, viewed 4 October 2019, <http://pc4tg.com.au/wp-content/uploads/2016/07/PC4-Principles-Statement-shared-care-2016-1.pdf>.

Cancer.Net 2019, Neuroendocrine tumors: symptoms and signs, viewed 27 September 2021, <https://www.cancer.net/cancer-types/neuroendocrine-tumors/symptoms-and-signs>.

Caplin ME, Pavel M, Phan AT, Cwikla JB, Sedlackova E, Thanh XMT, et al. 2021, ‘Lanreotide autogel / depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study’, vol. 71, no. 2, pp. 502–513.

Chan DL, Bernard E, Schembri G, Roach, P, Johnson M, Pavlakis N, et al. 2020, ‘High metabolic tumour volume on 18-fluorodeoxyglucose positron emission tomography predicts poor survival from neuroendocrine neoplasms’, Neuroendocrinology, vol. 110, pp. 950–958.

Clinical Oncology Society of Australia (COSA) 2013, Special Issue: COSA’s 40th Annual Scientific Meeting, Cancer Care Coming of Age, 12–14 November 2013, Adelaide Convention Centre, Asia-Pacific Journal of Clinical Oncology, vol. 9, no. 3, pp. 61–98.

Clinical Oncology Society of Australia (COSA) 2014, Psychosocial management of AYAs diagnosed with cancer: guidance for health professionals, COSA, Sydney, viewed 7 October 2019, <http://wiki.cancer.org.au/australia/COSA:Psychosocial_management_of_AYA_cancer_patients>.

Clinical Oncology Society of Australia (COSA) 2015, Cancer care coordinator: position statement, COSA, Sydney, viewed 22 July 2019, <https://www.cosa.org.au/media/332296/cancer-care-coordinator-position-statement_final-endorsed-by-council_161115_cnsa-logo.pdf>.

Clinical Oncology Society of Australia (COSA) 2016, Australasian tele-trial model: access to clinical trials closer to home using tele-health a national guide for implementation, v1.7, COSA, Sydney, viewed 18 July 2019, <https://www.cosa.org.au/media/332325/cosa-teletrial-model-final-19sep16.pdf>.

Clinical Oncology Society of Australia (COSA) 2018, COSA position statement on exercise in cancer care, COSA, Sydney, viewed 22 July 2019, <https://www.cosa.org.au/media/332488/cosa-position-statement-v4-web-final.pdf>.

Commonwealth Department of Health 2017, Out-of-pocket expenses for private medical treatment (informed financial consent), Commonwealth of Australia, Canberra.

Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, et al. 2018, ‘Clinical Oncology Society of Australia position statement on exercise in cancer care’, Medical Journal of Australia, vol. 209, no. 4, pp. 184–187.

Cormie P, Zopf EM, Zhang X, Schmitz KH 2017, ‘The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects’, Epidemiologic Reviews, vol. 39, no. 1, pp. 71–92.

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. 2017, ‘Trends in the prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States JAMA Oncology, vol. 3, no. 10, pp. 1335–1342.

Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G, et al. 2015, ‘Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations’, Annals of Oncology, vol. 26, no.1, pp 288–300.

Department of Health and Ageing 2013, South Australian gastroenteropancreatic neuroendocrine tumours pathway, Government of South Australia, Adelaide.

Emery J 2014, ‘Cancer survivorship – the role of the GP’, Australian Family Physician, vol. 43, no. 8, pp. 521–525.
eviQ 2019, ‘Safe handling and waste management of hazardous drugs’, Cancer Institute NSW, Sydney, viewed 22 July 2019, <https://www.eviq.org.au/clinical-resources/administration-of-antineoplastic-drugs/188-safe-handling-and-waste-management-of-hazardou>.

Ferrari A, Thomas D, Franklin A, Hayes-Lattin B, Mascarin M, van der Graaf W, et al. 2010, ‘Starting an adolescent and young adult program: some success stories and some obstacles to overcome’, Journal of Clinical Oncology, vol. 28, no. 32, pp. 4850–4857.

Fitch M 2000, ‘Supportive care for cancer patients’, Hospital Quarterly, vol. 3, no. 4, pp. 39–46.

Fitch MI 2008, ‘Supportive care framework’, Canadian Oncology Nursing Journal, vol. 18, no. 1, pp. 6–14.

Gangi A, Anaya DA 2020, ‘Surgical principles in the management of small bowel neuroendocrine tumors’, Current Treatment Options in Oncology, vol. 21, no. 11, Article 88.

GI Cancer Institute 2021, Control Nets, viewed 9 December 2021, <https://gicancer.org.au/clinical-trial/control-nets/>.

Gilligan T, Coyle N, Frankel RM, Berry DL, Bohlke K, Epstein, RM, et al. 2017, ‘Patient–clinician communication: American Society of Clinical Oncology consensus guideline’, Journal of Clinical Oncology, vol. 35, no. 31, pp. 3618–3623.

Grozinsky-Glasberg S, Grossman AB, Gross DJ 2015, ‘Carcinoid heart disease: from pathophysiology to treatment – “Something in the way it moves”’, Neuroendocrinology, no. 101, pp. 263–273.

Hack TF, Reuther DJ, Weir LM, Grenier D, Degner LF 2012, ‘Promoting consultation recording practice in oncology: identification of critical implementation factors and determination of patient benefit’, Psycho-Oncology, vol. 22, pp. 1273–1282.

Haines IE 2011, ‘Managing patients with advanced cancer: the benefits of early referral for palliative care’, Medical Journal of Australia, vol. 194, no. 3, pp. 107–108.

Hayes SC, Newton RU, Spence RR, Galvao DA 2019, ‘The Exercise and Sports Science Australia position statement: exercise medicine in cancer management’, Journal of Science and Medicine in Sport, vol. 22, no. 11, pp. 1175–1199.

Hewitt M, Greenfield S, Stovall E 2006, From cancer patient to cancer survivor: lost in transition, National Academies Press, Washington.

Hofman MS, Hicks RJ 2012, ‘Changing paradigms with molecular imaging of neuroendocrine tumours’, Discovery Medicine, vol. 14, no. 74, pp. 71–81.

I-Med Radiology Network 2020, 68Ga Dotatate PET-CT scan, viewed 27 September 2021, <https://i-med.com.au/68ga-dotatate-pet-ct-scan>.

Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, et al. 2017, ‘Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study’, Support Care Cancer, no. 10, pp. 3171–3179.

Kaltsas G, Caplin M, Davies P, Ferone D, Garcia-Carbonero R, Grozinsky-Glasberg S, et al. 2017, ‘ENETS 2017 Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors’, Neuroendocrinology, vol. 105, no. 3, pp. 245–254.

Knigge U, Capdevila J, Bartsch D, Baudin E, Falkerby J, Kianmanesh R, et al. 2017, ‘ENETS Consensus Recommendations for Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation, Neuroendocrinology, vol. 105, no.3, pp. 310-319.

Laidsaar-Powell R, Butow P, Boyle F, Juraskova 2018a, ‘Facilitating collaborative and effective family involvement in the cancer setting: guidelines for clinicians (TRIO guidelines-1)’, Patient Education and Counseling, vol. 101, no. 6, pp. 970–982.

Laidsaar-Powell R, Butow P, Boyle F, Juraskova 2018b, ‘Managing challenging interactions with family caregivers in the cancer setting: guidelines for clinicians (TRIO guidelines-2)’, Patient Education and Counselling, vol. 101, no. 6, pp. 983–994.

Lisy K, Langdon L, Piper A, Jefford M 2019, ‘Identifying the most prevalent unmet needs of cancer survivors in Australia: a systematic review’, Asia-Pacific Journal of Clinical Oncology, vol. 15, no. 5, pp. e68–e78.

Magi L, Mazzuca F, Rinzivillo M, Arrivi G, Pilozzi E, Prosperi et al. 2019, ‘Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center’, Journal of Clinical Medicine, vol. 8, no. 6, p. 910.

Michael M, Thursfield V, te Marvelde L, Kong G, Hick RJ 2021, ‘Incidence, prevalence and survival trends for neuroendocrine neoplasms in Victoria, Australia from 1982 to 2019. Based on site, grade and region ‘Asia-Pacific Journal of Clinical Oncology, 1–12. doi: 10.1111/ajco.13671.

Monterosso L, Platt V, Bulsara M, Berg M 2019, ‘Systematic review and meta-analysis of patient reported outcomes for nurse-led models of survivorship care for adult cancer patients’, Cancer Treatment Reviews Journal, no. 73, pp. 62–72.

My Health Record 2019, ‘What is My Health Record?’ Australian Government, Sydney, viewed 17 December 2019, <https://www.myhealthrecord.gov.au/for-you-your-family/what-is-my-health-record>.

National Comprehensive Cancer Network (NCCN) 2021, Guidelines Version 3: Neuroendocrine and adrenal, viewed 27 September 2021, <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1448>.

National Disability Insurance Agency 2018, ‘How the NDIS works’, NDIS, Canberra, viewed 3 June 2019, <https://www.ndis.gov.au/understanding/how-ndis-works>.

National Health and Medical Research Council (NHMRC) 2013, Personalised medicine and genetics, viewed 3 June 2019 <https://www.nhmrc.gov.au/about-us/publications/personalised-medicine-and-genetics>.

National Health and Medical Research Council (NHMRC) 2014, Talking with your patients about complementary medicine: a resource for clinicians, NHMRC, Canberra, viewed 18 February 2020, <https://www.caresearch.com.au/caresearch/ClinicalPractice/PatientConsiderations/ComplementaryTherapies/tabid/1258/Default.aspx>.

National Organisation for Rare Diseases (NORD) 2021, Carcinoid syndrome, viewed 27 September 2021, <https://rarediseases.org/rare-diseases/carcinoid-syndrome>.

NeuroEndocrine Cancer Australia (NECA) 2019a, Neuroendocrine tumours: a guide for patients, viewed 27 September 2021, <https://neuroendocrine.org.au/wp-content/uploads/2020/02/190822-NET-Patient-Booklet.pdf>.

NeuroEndocrine Cancer Australia (NECA) 2019b, A guide for health professionals, viewed 27 September 2021, <https://neuroendocrine.org.au/wp-content/uploads/2020/02/191009-UFD-NETs-forprofessionals.pdf>.

NeuroEndocrine Cancer Australia (NECA) 2020a, Symptoms and signs: clinical presentation, viewed 27 September 2021, <https://neuroendocrine.org.au/wp-content/uploads/2020/06/N5058-NECA_Symptoms_Download-v2.pdf>.

NeuroEndocrine Cancer Australia (NECA) 2020b, Carcinoid heart disease, viewed 27 September 2021, <https://neuroendocrine.org.au/wp-content/uploads/2020/07/N5058-NECA_CarcinoidHeartdisease_Download-v1-1.pdf>.

NeuroEndocrine Cancer Australia (NECA) 2021, National action plan, viewed 27 September 2021, <https://neuroendocrine.org.au/get-involved/net-national-action-plan/>.

O’Shea T, Druce M 2017 ‘When should genetic testing be performed in patients with neuroendocrine tumours?’ Review of Endocrine and Metabolic Disorders, vol. 18, no. 4, pp. 499– 515.

palliAGED 2018, ‘Needs Assessment’, Flinders University, Bedford Park, viewed 1 October 2019, <https://www.palliaged.com.au/tabid/4879/Default.aspx>.

Palliative Care Australia 2018, National Palliative Care Standards, 5th edn, Palliative Care Australia, Canberra, viewed 24 July 2019, <http://palliativecare.org.au/wp-content/uploads/dlm_uploads/2018/11/PalliativeCare-National-Standards-2018_Nov-web.pdf>.

Palliative Care Victoria 2019, ‘Spiritual care’, Palliative Care Victoria, Melbourne, viewed 22 July 2019, <https://www.pallcarevic.asn.au/healthcare-professionals/about-palliative-care/care/spiritual-care/>.

Perren A, Couvelard A, Scoazec JY, Costa F, Borbath I, Fave G, et al. 2017, ‘ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification’, Neuroendocrinology, vol. 105, no. 3, pp. 196-200.

Peter MacCallum Cancer Centre 2019, Community support organisations’ cancer survivorship care consensus statement, viewed 10 February 2020, <https://www.petermac.org/sites/default/files/media-uploads/NGO_ConsensusStatement.pdf>.

Queensland Health 2015, Sad news sorry business: guidelines for caring for Aboriginal and Torres Strait Islander people through death and dying, State Government of Queensland, Brisbane, viewed 22 July 2019, <https://www.health.qld.gov.au/__data/assets/pdf_file/0023/151736/sorry_business.pdf>.

Rinke A, Wittenberg M, Schade-Brittinger C, Aminssadati B, Ronicke e, Gress TM, et al. 2016, ‘Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotride LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors (PROMID): results of long-term survival’, Neuroendocrinology, vol. 104, no. 1, pp. 260–232.

Rogel Cancer Centre University of Michigan 2021, ‘Endrocrine syndromes / endocrine tumor genetics, viewed 27 September 2021, <https://www.rogelcancercenter.org/endocrine-cancer/familial-neuroendocrine-syndromes>.

Roswell Park 2021, Prevention and detection of neuroendocrine tumors, viewed 27 September 2021, <https://www.roswellpark.org/cancer/neuroendocrine-tumors/prevention-detection>.

Safer Care Victoria 2021, Data linkage plays a key role in COVID-19 pandemic response, State of Victoria, Melbourne, viewed 4 March 2022, <https://www.bettersafercare.vic.gov.au/news-and-media/data-linkage-plays-a-key-role-in-covid-19-pandemic-response>.

Silver JK 2015, ‘Cancer prehabilitation and its role in improving health outcomes and reducing health care costs’, Seminars in Oncology Nursing, vol. 31, no. 1, pp. 1–3.

Silver JK, Baima J 2013, ‘Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes’, American Journal of Physical Medicine & Rehabilitation, vol. 92, no. 8, pp. 715–727.

Singh S, Moody L, Chan DL, Metz DC, Strosberg J, Asmis T, et al. 2018, ‘Follow-up recommendations for completely resected gastroenteropacreatic neuroendocrine tumors’, JAMA Oncology, vol. 4, no. 11, pp. 1597–1604.

Sjoquist K, Zalcberg J 2013, ‘Clinical trials – advancing cancer care’, Cancer Forum, vol. 37, no. 1, pp. 80–88.

Smith A, Bellizzi K, Keegan T, Zebrack B, Chen V, Neale A, et al. 2013, ‘Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience Study’, Journal of Clinical Oncology, vol. 31, no. 17, pp. 2136–2145.

Smith S, Case L, Waterhouse K, Pettitt N, Beddard L, Oldham J, et al. 2012, A blueprint of care for teenagers and young adults with cancer, Teenage Cancer Trust, Manchester, UK.

Steer B, Marx G, Singhal N, McJannett M, Goldstein D, Prowse R 2009, ‘Cancer in older people: a tale of two disciplines’, Internal Medicine Journal, vol. 39, pp. 771–775.

Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. 2017 ‘Trial of 177Lu-Dotatate for midgut neuroendocrine tumors’ New England Journal of Medicine, vol. 376, no. 2, pp. 125–135.

Tan SY, Turner J, Kerin-Ayres K, Butler S, Deguchi C, Khatri S, et al. 2019, ‘Health concerns of cancer survivors after primary anti-cancer treatment’, Support Cancer Care, no. 10, pp. 3739–3747.

The Centre for Victorian Data Linkage (CVDL) 2021, The Centre for Victorian Data Linkage overview, State of Victoria, Melbourne.

Temel J, Greer J, Muzikansky A, Gallagher E, Admane S, Jackson V 2010, ‘Early palliative care for patients with non-metastatic non-small cell lung cancer’, New England Journal of Medicine, vol. 363, no. 8, pp. 733–742.

Toomey PG, Teta AF, Patel KD, Ross SB, Rosemurgy AS 2016 ‘High-volume surgeons vs high volume hospitals; are best outcomes more due to who or where?’ The American Journal of Surgery, vol. 211, no.1, pp. 59–63.

Tsoli M, Chatzellis E, Koumarianou A, Kolomodi D, Kaltsas G 2019 ‘Current best practice in the management of neuroendocrine tumors’, Therapeutic Advances in Endocrinology and Metabolism, vol. 10. doi: 10.3390/jcm8060910.

Vardy JL, Raymond JC, Koczwara B, Lisy K, Cohn RJ, Joske D, et al. 2019, ‘Clinical Oncology Society of Australia position statement on cancer survivorship care’, Australian Journal of General Practice, vol. 48, no.12, pp. 833–836.

Vijayvergia N, Denlinger CS 2015, ‘Lifestyle factors in cancer survivorship: where we are and where we are headed’, Journal of Personalized Medicine, vol. 5, no. 3, pp. 243–263.

Wildiers H, Heeren P, Puts M, Topinkova E, Maryska LG, Janssen-Heijnen MLG, et al. 2014, ‘International Society of Geriatric Oncology Consensus on geriatric assessment in older patients with cancer’, Journal of Clinical Oncology, vol. 32, no. 24, pp. 2595–2603.

World Health Organization (WHO) 2018, ‘Malnutrition’, WHO, Geneva, viewed 18 July 2019, <https://www.who.int/news-room/fact-sheets/detail/malnutrition>.

World Health Organization (WHO) 2020, WHO report on cancer: setting priorities, investing wisely and providing care for all, WHO, Geneva, viewed 17 March 2022.

Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. 2014, ‘Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial’, Lancet, vol. 383, no. 9930, pp. 1721–1730.